| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/05/2004 | WO2004064709A2 Thrombolytic agent |
| 08/05/2004 | WO2004054608A3 Lactoferrin in the reduction of pain |
| 08/05/2004 | WO2004050687A3 Cyclosporins for the treatment of autoimmune diseases |
| 08/05/2004 | WO2004047859A3 Prekallikrein depleted plasma derived albumin fraction |
| 08/05/2004 | WO2004043996A3 Ligands |
| 08/05/2004 | WO2004043373A3 Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 08/05/2004 | WO2004041159A3 Composition and method for enhancing immune response of swine |
| 08/05/2004 | WO2004040262A3 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 08/05/2004 | WO2004035762A3 Microencapsulation and sustained release of biologically active polypeptides |
| 08/05/2004 | WO2004033645A3 Methods of regulating body weight |
| 08/05/2004 | WO2004033486A3 Production of homotrimeric fusion proteins |
| 08/05/2004 | WO2004031276A8 Method of inducing maturation of dendritic cells and uses therefor |
| 08/05/2004 | WO2004029246A3 Integrase cofactor |
| 08/05/2004 | WO2004029023A3 Cell-surface estrogen receptor and related compositions and methods |
| 08/05/2004 | WO2004028339A3 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 08/05/2004 | WO2004025302A3 Method for the identification of proteins specific for renal cell carcinoma and use thereof |
| 08/05/2004 | WO2004024875A3 Mammalian megakaryocyte progenitor cell |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004021991A3 Asialo-interferons and the treatment of liver cancer |
| 08/05/2004 | WO2004020465A3 Proteins involved in the regulation of energy homeostasis |
| 08/05/2004 | WO2004014882A3 Proteasome inhibitors : peptide derivatives having c-terminal heteroaryl groups |
| 08/05/2004 | WO2004009615A3 Cd40-ligand lacking native-pattern glycosylation |
| 08/05/2004 | WO2004000870A3 Two synthetic peptides for treatment and prevention of cancers |
| 08/05/2004 | WO2003102173A8 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 08/05/2004 | WO2003072058A3 Dna-binding polyamide drug conjugates |
| 08/05/2004 | WO2003054550A8 Uses of an endothelial cell receptor |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003044045A3 Peptides promoting cell adherence, growth and secretion |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003040321A3 Antisense modulation of eif2c1 expression |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003037165A3 System and method for the pretreatment of the endplates of an intervertebral disc |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003022227A3 Antisense modulation of vascular endothelial growth factor receptor-1 expression |
| 08/05/2004 | WO2003016553A3 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | WO2003012063A3 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | WO2002102976A3 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/05/2004 | WO2002090552A3 Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing |
| 08/05/2004 | WO2002081648A3 Synthesis and secretion of recombinant lysosomal enzymes by liver |
| 08/05/2004 | WO2002064014A3 Endomural therapy |
| 08/05/2004 | US20040152884 Methods and materials relating to alpha-2-macroglobulin like polypeptides and polynucleotides |
| 08/05/2004 | US20040152875 Novel purinergic receptor |
| 08/05/2004 | US20040152874 Comprises transport protein for identifying modulators for prevention and treatment of transport, neurological, muscular, immunological, cell proliferative and iron metabolism disorders |
| 08/05/2004 | US20040152871 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders |
| 08/05/2004 | US20040152869 Comprises amino acid sequences which serve as substrates for a disintegrin and metalloprotease (ADAM) for use in identification of modulator for treatment of asthma |
| 08/05/2004 | US20040152753 Methods of use for novel sulfur containing organic nitrate compounds |
| 08/05/2004 | US20040152703 Controlling fertility; contraceptiives |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152684 Administering at least one 17 alpha -fluoralkylated progesterone receptor antagonist to the female subject during the post-ovulatory phase of the endometrial cycle inhibiting the occurrence of advanced endometrium maturation |
| 08/05/2004 | US20040152673 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152672 Indole compounds useful for the treatment of cancer |
| 08/05/2004 | US20040152661 Methods and compositions for treating viral diseases |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152654 Inhibitory oligonucleotides targeted to Bcl-2 |
| 08/05/2004 | US20040152653 Administering a pharmacologic complex to the airway epithelium via its luminal surface, wherein the complex comprises a ligand for serpin enzyme complex receptor (SecR) and a pharmacologic agent |
| 08/05/2004 | US20040152652 Therapy of inflammatory disorder in an individual comprising administering oligonucleotide up to 30 nucleotides in length complementary to a nucleic acid molecule encoding human tumor necrosis factor- alpha |
| 08/05/2004 | US20040152651 Regulation of transcription elongation factors |
| 08/05/2004 | US20040152649 For prophylaxis and therapy of infectious disease, allergy, cancer |
| 08/05/2004 | US20040152647 For use in gene therapy |
| 08/05/2004 | US20040152644 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152643 For therapy of neoplastic diseases |
| 08/05/2004 | US20040152642 For therapy of of neoplastic diseases |
| 08/05/2004 | US20040152639 Peptide hormone analogs of GnRH designed to be useful in male and female fertility regulation, post-coital contraception and as a menses-inducing agent, for managing ovarian cyst, polycystic ovarian disease, in vitro fertilization |
| 08/05/2004 | US20040152638 Protegrins |
| 08/05/2004 | US20040152637 To assess the risk of individuals to suffer from vascular contraction of coronary arteries in mammals; for therapy of vascular contraction of coronary arteries |
| 08/05/2004 | US20040152636 For therapy of diseases or disorders characterized by undesirable excessive vascularization such as tumors, rheumatoid arthritis, psoriasis, atherosclerosis, diabetic and other retinopathies, retrolental fibroplasia, macular degeneration |
| 08/05/2004 | US20040152635 For blocking the infectiousness of human immunodeficiency virus (HIV) in vivo or in vitro |
| 08/05/2004 | US20040152634 Chemokine antagonists and uses thereof |
| 08/05/2004 | US20040152633 Kunitz-type sequences and polypeptides |
| 08/05/2004 | US20040152630 14-3-3 Binding molecules as sensitizers for anticancer therapies |
| 08/05/2004 | US20040152628 Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof |
| 08/05/2004 | US20040152627 For therapy of orthopaedic and dental, including periodontal, diseases |
| 08/05/2004 | US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof |
| 08/05/2004 | US20040152625 Administering 5,11-Dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one and one or more inhibitors of CYP 450 for therapy of HIV |
| 08/05/2004 | US20040152624 Oral lactoferrin in the treatment of sepsis |
| 08/05/2004 | US20040152623 Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease |
| 08/05/2004 | US20040152622 Closed loop therapy system for controlling a concentration of a substance, such as blood glucose concentration, in the body of a user |
| 08/05/2004 | US20040152179 Receptor-mediated uptake of an extracellular Bcl-xL fusion protein inhibits apoptosis |
| 08/05/2004 | US20040152169 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (MPIF-1), monocyte colony inhibitory factor (M-CIF), and macrophage inhibitory factor-4 (MIP-4) |
| 08/05/2004 | US20040152164 62 human secreted proteins |
| 08/05/2004 | US20040152163 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 08/05/2004 | US20040152162 Polypeptides capable of interacting with human topoisomerase III alpha |
| 08/05/2004 | US20040152161 Comprises type I membrane protein receptor for identifying modulators for treatment of cell proliferation, leukopenia, anemia, thrombocytopenia, osteoporosis and neurodegenerative disorders |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | US20040152156 Nucleotide sequences coding counter-ligands for several receptors expressed on lymphocytes for use in diagnosis and treatment of asthma, allergic or inflammatory disease |
| 08/05/2004 | US20040152143 Growth differentiation factor-9 |
| 08/05/2004 | US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering |
| 08/05/2004 | US20040152138 Using dementia related osteoponton (DROPN) peptides to diagnose, prognose and identify treatments for progressive neurodegenerative diseases |
| 08/05/2004 | US20040152136 I dentifying modulators which alter binding of receptors and neuromedins for use in treatment of obesity, hypertension or stress-related diseases |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152125 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 08/05/2004 | US20040152115 directed toward modulating oxidative damage to intracellular components such as mitochondrial DNA (mtDNA) and mitochondrial protein |
| 08/05/2004 | US20040152111 Compositions and methods for diagnosing and treating mood disorders |
| 08/05/2004 | US20040152105 Immune modulatory compounds and methods |
| 08/05/2004 | US20040152102 for athersclerosis detection/treatment based on gene expression; genetic engineering |
| 08/05/2004 | US20040152101 for diagnostic/therapeutic/prophylactics for neurodegenerative diseases, brain dysfunctions, cancers, gastrointestinal/circulatory/endocrine diseases and cell death; genetic engineering |
| 08/05/2004 | US20040152088 Methods for diagnosing and treating heart disease |
| 08/05/2004 | US20040152079 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |